Skip to main content
ITRM logo
ITRM
(NASDAQ)
Iterum Therapeutics plc
$0.05-- (--)
Loading... - Market loading

Iterum Therapeutics (ITRM) Stock Price & Financial Analysis

Iterum Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.05 - $0.06
52-Week High$1.28
52-Week Low$0.01
Open$0.05
Volume40.11K
Average Volume (3M)527.99K
Market Cap2.06M
Shares Outstanding45.80M
Price to Sales (P/S)5.28
Price to Book (P/B)-0.28
EV/EBITDA-1.26
Revenue (TTM)390.00K
Net Income (TTM)-26.96M
Free Cash Flow (TTM)-19.53M
EPS (TTM)$-0.74
Profit Margin-6913.08%
Operating Margin-5292.31%
50-Day MA$0.08
200-Day MA$0.42
52-Week Change-94.55%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Iterum Therapeutics

What is the current stock price for ITRM?

As of the latest trading session, ITRM stock trades at $0.04. The 52-week range is $0.01–$1.28, with a day range of $0.04–$0.06.

What is the P/E ratio for ITRM?

The P/E ratio (Price-to-Earnings) for ITRM is shown in the Key Statistics section. This valuation metric helps compare Iterum Therapeutics plc to industry peers.

Does ITRM pay dividends?

Iterum Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ITRM?

Analyst ratings and recommendations for ITRM are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ITRM?

Iterum Therapeutics's market capitalization is $2.1M, classifying it as a micro-cap company. Iterum Therapeutics operates in the Healthcare sector within the Biotechnology industry.